SEC Filing Summary: Bionomics Limited (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Bionomics Limited, a foreign issuer, for the month of November 2023. The report discloses a corporate governance event regarding the Board of Directors. The filing date is November 28, 2023.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change disclosed is the retirement of a Board Member. Dr. Errol De Souza will not be standing for re-election to the Company's Board of Directors at the Annual General Meeting (AGM) scheduled for November 30, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are detailed beyond the standard disclosure of the board member's departure.
Key Facts for Investors to Verify
- Dr. Errol De Souza is retiring from the Board of Directors.
- The decision was announced to shareholders on November 28, 2023, prior to the AGM on November 30, 2023.
- The filing does not include financial performance data for the period.